Status:
UNKNOWN
TAVR Without Predilatation
Lead Sponsor:
University Hospital, Montpellier
Conditions:
Aortic Stenosis
Eligibility:
All Genders
18+ years
Brief Summary
The procedure is performed via transfemoral or transcaprotid access; Patients were confirmed to be eligible for TAVR by a multidisciplinary heart team including at least an interventional cardiologist...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- \- patients undergoing TAVR via transfemoral or rascoarotid access
- Exclusion criteria:
- \- others access (subclavian, apical, transaortic)
Exclusion
Key Trial Info
Start Date :
June 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 1 2022
Estimated Enrollment :
138 Patients enrolled
Trial Details
Trial ID
NCT04350658
Start Date
June 1 2020
End Date
April 1 2022
Last Update
November 11 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Uhmontpellier
Montpellier, France, 34295